- $32.23bn
- $32.68bn
- $4.34bn
EU M&A rules morph from growth catalyst to weapon
Brief: Illumina Launches New Business To Accelerate Technology And Data-Driven Discovery
US. STOCKS ON THE MOVE-Vertex, IBM, Silver Miners
US. STOCKS ON THE MOVE-Vertex, IBM, silver miners
Medical device makers fall after US government probes of medical device imports
Illumina sued by rival Element over gene-sequencing technology
Timeline: Trump's trade war with China in 2025
Brief: Illumina® Protein Prep Launches To Drive Greater Proteomic Insights For Improved Drug Discovery And Development
Brief: Illumina® Protein Prep Launches To Drive Greater Proteomic Insights For Improved Drug Discovery And Development
Factbox: Healthcare firms see growing activist investor involvement in the past year
Brief: Carl Icahn Raises Shared Share Stake In Centuri Holdings, Dissolves In Dana,Illumina
Timeline: Trump's trade war with China in 2025
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Amazon, Appfolio
Illumina Inc reports results for the quarter ended June 30 - Earnings Summary
Illumina Q2 revenue falls 3%, but beats expectations
Brief: Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Canopy Growth
Citi flags uncertainty in life science sector as funding shifts and tariffs bite